Literature DB >> 23666961

Changes in bone resorption across the menopause transition: effects of reproductive hormones, body size, and ethnicity.

MaryFran R Sowers1, Huiyong Zheng, Gail A Greendale, Robert M Neer, Jane A Cauley, Jayne Ellis, Sarah Johnson, Joel S Finkelstein.   

Abstract

OBJECTIVE: Our objective was to characterize changes in bone resorption in relation to the final menstrual period (FMP), reproductive hormones, body mass index (BMI), and ethnicity.
METHODS: Urinary type I collagen N-telopeptide (NTX), estradiol, and FSH levels were measured annually for up to 8 years spanning the menopause transition in 918 African American, Chinese, Japanese, or Caucasian women.
RESULTS: Urinary NTX began to increase sharply about 2 years before the FMP, reaching its peak level about 1 to 1.5 years after the FMP. NTX levels declined modestly from 2 to 6 years after the FMP but remained about 20% higher than before the menopause transition. The sharp rise in FSH occurred in conjunction with a sharp decline in estradiol and shortly after FSH levels began increasing rapidly. The mean increase in urinary NTX across the menopause transition was greatest in women with BMI <25 kg/m² and smallest in women with BMI >30 kg/m². Increases in NTX were greatest in Japanese women and smallest in African Americans. These differences were attenuated, but not eliminated, when analyses were adjusted for covariates, particularly BMI.
SUMMARY: During the menopause transition, a decline in ovarian function beginning about 2 years before the FMP is followed by an increase in bone resorption and subsequently by bone loss. The magnitude of the increase in bone resorption is inversely associated with BMI. Ethnic differences in changes in bone resorption are attenuated, but not eliminated, by adjustment for BMI. Ethnic differences in BMI, and corresponding ethnic differences in bone resorption, appear to account for much of the ethnic variation in perimenopausal bone loss.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23666961      PMCID: PMC3701268          DOI: 10.1210/jc.2012-4113

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  45 in total

1.  FSH directly regulates bone mass.

Authors:  Li Sun; Yuanzhen Peng; Allison C Sharrow; Jameel Iqbal; Zhiyuan Zhang; Dionysios J Papachristou; Samir Zaidi; Ling-Ling Zhu; Beatrice B Yaroslavskiy; Hang Zhou; Alberta Zallone; M Ram Sairam; T Rajendra Kumar; Wei Bo; Jonathan Braun; Luis Cardoso-Landa; Mitchell B Schaffler; Baljit S Moonga; Harry C Blair; Mone Zaidi
Journal:  Cell       Date:  2006-04-21       Impact factor: 41.582

2.  Bone density screening intervals for osteoporosis: one size does not fit all.

Authors:  Elaine W Yu; Joel S Finkelstein
Journal:  JAMA       Date:  2012-06-27       Impact factor: 56.272

3.  A prospective study of bone loss in menopausal Australian-born women.

Authors:  J R Guthrie; P R Ebeling; J L Hopper; E Barrett-Connor; L Dennerstein; E C Dudley; H G Burger; J D Wark
Journal:  Osteoporos Int       Date:  1998       Impact factor: 4.507

4.  Age and menopause-related changes in indices of bone turnover.

Authors:  P J Kelly; N A Pocock; P N Sambrook; J A Eisman
Journal:  J Clin Endocrinol Metab       Date:  1989-12       Impact factor: 5.958

5.  Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) study group.

Authors:  P Ravn; G Cizza; N H Bjarnason; D Thompson; M Daley; R D Wasnich; M McClung; D Hosking; A J Yates; C Christiansen
Journal:  J Bone Miner Res       Date:  1999-09       Impact factor: 6.741

6.  An Integrated Quantitative Methodology to Longitudinally Characterize Complex Dynamic Processes Associated with Ovarian Aging and the Menopausal Transition.

Authors:  Huiyong Zheng; Maryfran Sowers; John F Randolph; Siobán D Harlow
Journal:  J Syst Cybern Inf       Date:  2011

7.  Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.

Authors:  P Garnero; E Sornay-Rendu; M C Chapuy; P D Delmas
Journal:  J Bone Miner Res       Date:  1996-03       Impact factor: 6.741

8.  Bone mineral density changes during the menopause transition in a multiethnic cohort of women.

Authors:  Joel S Finkelstein; Sarah E Brockwell; Vinay Mehta; Gail A Greendale; MaryFran R Sowers; Bruce Ettinger; Joan C Lo; Janet M Johnston; Jane A Cauley; Michelle E Danielson; Robert M Neer
Journal:  J Clin Endocrinol Metab       Date:  2007-12-26       Impact factor: 5.958

9.  Bone loss and bone size after menopause.

Authors:  Henrik G Ahlborg; Olof Johnell; Charles H Turner; Gunnar Rannevik; Magnus K Karlsson
Journal:  N Engl J Med       Date:  2003-07-24       Impact factor: 91.245

10.  Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.

Authors:  P Garnero; W J Shih; E Gineyts; D B Karpf; P D Delmas
Journal:  J Clin Endocrinol Metab       Date:  1994-12       Impact factor: 5.958

View more
  41 in total

1.  Femoral Neck External Size but not aBMD Predicts Structural and Mass Changes for Women Transitioning Through Menopause.

Authors:  Karl J Jepsen; Andrew Kozminski; Erin Mr Bigelow; Stephen H Schlecht; Robert W Goulet; Sioban D Harlow; Jane A Cauley; Carrie Karvonen-Gutierrez
Journal:  J Bone Miner Res       Date:  2017-01-30       Impact factor: 6.741

Review 2.  Regulation of Bone Metabolism by Sex Steroids.

Authors:  Sundeep Khosla; David G Monroe
Journal:  Cold Spring Harb Perspect Med       Date:  2018-01-02       Impact factor: 6.915

3.  Anti-Müllerian hormone, follicle stimulating hormone, antral follicle count, and risk of menopause within 5 years.

Authors:  Catherine Kim; James C Slaughter; Erica T Wang; Duke Appiah; Pamela Schreiner; Benjamin Leader; Ronit Calderon-Margalit; Barbara Sternfeld; David Siscovick; Melissa Wellons
Journal:  Maturitas       Date:  2017-05-01       Impact factor: 4.342

Review 4.  Bone Health During the Menopause Transition and Beyond.

Authors:  Arun S Karlamangla; Sherri-Ann M Burnett-Bowie; Carolyn J Crandall
Journal:  Obstet Gynecol Clin North Am       Date:  2018-10-25       Impact factor: 2.844

5.  Urinary N-telopeptide and Rate of Bone Loss Over the Menopause Transition and Early Postmenopause.

Authors:  Albert Shieh; Shinya Ishii; Gail A Greendale; Jane A Cauley; Joan C Lo; Arun S Karlamangla
Journal:  J Bone Miner Res       Date:  2016-10-21       Impact factor: 6.741

6.  Relationship between A163G osteoprotegerin gene polymorphism and other osteoporosis parameters in Roma and non-Roma postmenopausal women in eastern Slovakia.

Authors:  Marta Mydlárová Blaščáková; Ľudmila Blaščáková; Janka Poráčová; Jozef Mydlár; Janka Vašková; Jarmila Bernasovská; Iveta Boroňová; Eva Petrejčíková; Ivan Bernasovský
Journal:  J Clin Lab Anal       Date:  2016-11-15       Impact factor: 2.352

7.  Efficacy of Osteoporosis Prevention Smartphone App.

Authors:  Polly Ryan; Roger L Brown; Mary Ellen Csuka; Paula Papanek
Journal:  Nurs Res       Date:  2020 Jan/Feb       Impact factor: 2.381

Review 8.  Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease.

Authors:  Matthew B Greenblatt; Joy N Tsai; Marc N Wein
Journal:  Clin Chem       Date:  2016-12-09       Impact factor: 8.327

9.  Soluble CD14 and fracture risk.

Authors:  M Bethel; P Bůžková; H A Fink; J A Robbins; J A Cauley; J Lee; J I Barzilay; D I Jalal; L D Carbone
Journal:  Osteoporos Int       Date:  2015-12-11       Impact factor: 4.507

10.  Bone mineral density in midlife women: the Study of Women's Health in Qatar.

Authors:  L M Gerber; A Bener; H M Al-Ali; M Hammoudeh; L Q Liu; M Verjee
Journal:  Climacteric       Date:  2014-10-23       Impact factor: 3.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.